{"schema_version":"secwatch.filing_event.v1","accession":"0001006837-25-000118","form_type":"8-K","ticker":"VATE","cik":"0001006837","company_name":"INNOVATE Corp.","filed_at":"2025-10-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.501653+00:00","generated_at":"2026-05-17T02:56:09.524602+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"MediBeacon receives NMPA approval for Transdermal GFR System in China; sales expected by year-end","bullets":["NMPA approved Lumitrace (relmapirazin) injection and MediBeacon TGFR Monitor/Sensor for kidney function assessment in China.","TGFR system will be available for sale in China before end of 2025; commercial partnership with Huadong Medicine (est. 2019).","CKD affects ~11% of China's 1.4B people; TGFR offers point-of-care tGFR without blood draws or estimating equations."],"urls":{"canonical":"https://secwatch.observer/filing/0001006837-25-000118","json":"https://secwatch.observer/filing/0001006837-25-000118.json","markdown":"https://secwatch.observer/filing/0001006837-25-000118.md","text":"https://secwatch.observer/filing/0001006837-25-000118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006837/000100683725000118/0001006837-25-000118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006837/000100683725000118/hchc-20251021.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:56:09.524602+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}